U.S. Beverage Stock News

US defense and aerospace stocks are back in focus as fresh government commitments to border security, Space Force expansion, and recruitment funding reshape expectations for contractors and service providers. With US$70b earmarked for border initiatives, including US$26b for Border Patrol, investors are looking closely at companies tied to military, space, and security spending. This article outlines how the latest policy moves may influence revenues, risk, and sentiment, and then examines 3...

FuelCell Energy has been added to multiple Russell equity indices, including the Russell 2000 and Russell 3000. This index inclusion marks a new milestone for NasdaqGM:FCEL and could draw more attention from institutional investors and index funds. The change represents a shift in the company’s market profile that has not been highlighted in recent coverage. FuelCell Energy enters these indices with recent share price momentum, with NasdaqGM:FCEL trading at $28.11 and up 17.1% over the past...

Europe’s pullback from U.S. LNG in June, a large energy purchase pledge that is proving hard to meet, and gas storage levels sitting at a 15 year low have put U.S. energy exporters under a brighter spotlight. Contract uncertainty today sits alongside the possibility of higher U.S. LNG flows to Europe after 2027, creating both risk and opportunity for investors watching liquefied natural gas. This article walks through 3 stocks from our U.S. Energy Exporters screener that appear positively...

Lockheed Martin is back in focus after a Citi upgrade to Buy, a higher price target of $582, and a series of fresh U.S. defense contracts, including a $347.5 million Army deal and a $35.5b THAAD interceptor award. For income investors, this kind of contract visibility can matter just as much as headline stock moves like today’s 4.2% gain. This article looks at 3 large cap dividend stocks from our screener that are directly exposed to this news and aims to help you decide whether these...

Regencell Bioscience Holdings (RGC) is back in focus after disclosing cooperation with a U.S. Department of Justice investigation into trading in its shares, alongside mounting legal costs and going concern warnings. See our latest analysis for Regencell Bioscience Holdings. At a share price of $6.37, Regencell Bioscience Holdings has seen sharp selling pressure recently, with the 30 day share price return down 68.13% and the year to date share price return down 68.99%. The three year total...

US industrial and electrical equipment stocks are suddenly in the spotlight as data centre projects face potential moratoriums, communities push back on new builds, and transformer shortages expose how reliant the US is on imports. At the same time, foreign groups such as Hitachi and Siemens are committing fresh capital to US manufacturing, and China is reportedly lining up a $295b data centre buildout of its own. For investors, this mix of risk and new investment could reshape which US...

With warnings about stretched valuations, technical divergences and rising bear market risk back in the headlines, many investors are looking past the hottest AI hardware and megacap stories and paying closer attention to balance sheets and cash levels. The Cash-Rich Companies screener focuses on businesses with low debt, solid cash positions and valuations that are not out of line with fundamentals. These traits may give such stocks more room to respond to a sharp pullback or a sudden shift...

Sunbelt Rentals Holdings (SUNB) has just been added to several Russell indexes, including the Russell 1000 and Russell 3000. This event can reshape how index funds and institutional investors treat the stock. See our latest analysis for Sunbelt Rentals Holdings. Against this backdrop, Sunbelt Rentals Holdings' share price has eased in the short term, with a 1-day share price return of 0.82% decline, a 7-day return of 2.34% decline and a 30-day return of 8.85% decline. Momentum over longer...

Glass House Brands recently uplisted to the New York Stock Exchange under the ticker GLAS after restructuring its operations around medical cannabis and moving its adult-use businesses into a wholly owned subsidiary. This shift, coming after federal rescheduling of medical cannabis to Schedule III, reshapes Glass House’s business profile and potential market access, including future interstate and European opportunities. Next, we’ll examine how Glass House’s NYSE uplisting and medical focus...

The live service model that once helped power hits like Destiny 2 is now under pressure, and that shift is rippling through gaming stocks. As Bungie, owned by Sony, pulls back on Destiny 2 updates and the industry leans toward blockbuster single player titles, investors are reassessing where future cash flows might come from. This article explains how that news connects to three stocks exposed to the same forces, highlighting one where the changing model could be a relative positive and two...

Agilent Technologies (NYSE:A) has released an AI powered xCELLigence RTCA eSight AI software module for biopharma research. The upgrade is designed to automate and standardize cell imaging analysis workflows, which may help reduce manual steps and variability for researchers. The launch introduces AI driven experimental analysis tools that support high throughput drug discovery and related applications. Agilent Technologies enters this launch with its stock at $130.69 and a mixed recent...

Some of the losses seen by insiders who purchased US$372.5k worth of Rapid7, Inc. ( NASDAQ:RPD ) shares over the past...

We'd be surprised if C3.ai, Inc. ( NYSE:AI ) shareholders haven't noticed that the President, Stephen Ehikian, recently...

O'Reilly Automotive (NasdaqGS:ORLY) has reportedly made a cash offer to acquire Genuine Parts Company's auto parts division. The proposed deal is estimated at US$10b or more and would be O'Reilly's largest acquisition since 2008. Genuine Parts is weighing options that may include a spinoff or a sale to O'Reilly or another bidder. O'Reilly Automotive is a major US auto parts retailer serving both professional repair shops and do it yourself customers. The auto parts sector has been shaped by...

ADMA Biologics stock has delivered a very large 5 year gain, yet the broader valuation checks currently lean cheap, setting up a clear tension between past returns and what the market is asking investors to pay today. Over the past 5 years, ADMA Biologics has returned almost 7x, which puts extra focus on whether the current price still reflects a reasonable entry point after such a strong run. Potential margin expansion and progress on its hyperimmune globulin candidate for pneumococcal...

Heightened political tension around President Trump’s July 4 speech, visible partisan branding at the Freedom 250 events, and tighter security on the streets are all feeding into a broader debate about where risk, and potential opportunity, now sit in the market. Defense and security stocks are squarely in that conversation, as government priorities, protest activity, and even extreme weather can all shape budgets and sentiment. This article walks through 3 stocks from our Defense and...

Carlisle Companies has submitted multiple unsolicited acquisition proposals to Owens Corning (NYSE:OC). The approaches signal external interest in acquiring control of Owens Corning and combining the businesses. The proposals introduce the possibility of a change in ownership structure and future direction for Owens Corning. Owens Corning operates as a building products company, with exposure to insulation, roofing, and related materials that are tied to construction and renovation...

Chagee Holdings stock has seen a steep share price decline over the past year, yet its valuation checks currently lean cheap, which sets up a clear tension between weak recent returns and what the broader metrics suggest about value. Over the last 1 year, Chagee Holdings is down 57.1%, which means anyone holding through that period has experienced a substantial drawdown. Future revenue and cash flow execution may support rebuilding confidence in the business, while any pressure on margins or...

Short term Treasury yields above 4% and banks lifting deposit rates are putting cash and ultra short fixed income back in the spotlight. For investors weighing how to respond to higher yields and shifting expectations for Federal Reserve policy, a key question is which stocks are most exposed to these moves in short duration markets. This article looks at three stocks from a Short Term Fixed Income Opportunities screener that appear positively tied to this rate backdrop, helping you consider...

Fluor stock has delivered a very strong 187.3% return over the past 5 years, and the current valuation checks and recent share price pullback raise a question about how much upside may still be priced in. Over 5 years, Fluor has returned 187.3%, which puts recent short term weakness into the context of a long period of strong gains. Recent progress on large infrastructure and energy projects can support confidence in future cash generation, while execution risk on complex contracts and large...

Tariff headlines can make it hard to judge which U.S. stocks might quietly benefit or face added friction. With Trump’s levies generating record government revenue while much of U.S. trade still enters duty free, the picture for consumer staples is more nuanced than it first appears. This article focuses on three large U.S. consumer staples stocks exposed to the latest tariff backdrop and explains how their essential goods focus, supply chains, and pricing power could shape the way they...

Capricor Therapeutics has delivered a very large 3 year gain, yet the stock now screens as overvalued on market multiples and earns a mixed valuation score, so the recent pullback raises questions about how much of the story is already reflected in the price. Capricor Therapeutics has returned about 4.4x over the past 3 years, which puts extra focus on whether the current share price leaves enough room for disappointment. The upcoming FDA review and PDUFA decision for Deramiocel can be a key...

US regional banks are back in focus as investors assess what Kevin Warsh’s first Federal Reserve meeting minutes might signal for future interest rates. Regional lenders with solid health and risk profiles can be particularly sensitive to changes in the spread between what they earn on loans and pay on deposits. This article looks at how that potential policy direction, and the stronger US dollar that has followed expectations of higher rates, could affect certain regional bank stocks. Ahead,...

Martin Marietta Materials (NYSE:MLM) has agreed to a definitive merger with Lhoist North America valued at about $13.5b. The transaction will combine Martin Marietta Materials' aggregates and heavy building materials operations with Lhoist's North American lime and limestone business. The deal represents an expansion of Martin Marietta Materials' presence in the broader construction materials and industrial minerals space. Martin Marietta Materials operates in aggregates and heavy building...